Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

280.18
-6.1100-2.13%
Volume:158.24K
Turnover:44.66M
Market Cap:5.59B
PE:28.85
High:286.27
Open:286.27
Low:279.87
Close:286.29
52wk High:326.63
52wk Low:158.13
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.86
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.77
PE(LYR):45.71

Loading ...

Jun 12, 2019

Major Issues Report

Current report, item 8.01
Jun 10, 2019

Major Issues Report

Current report, items 5.02 and 5.07
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Major Issues Report

Current report, item 8.01
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 24, 2019

Major Issues Report

Current report, items 1.01 and 8.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Dec 06, 2018

Major Issues Report

[Amend] Current report, item 9.01
Nov 13, 2018

Beneficial Ownership Change

Mar 07, 2018

Major Issues Report

Jan 17, 2018

Correspondence

Nov 02, 2017

[Rev.]Quaterly Report